Updates

May 23, 2019May 23, 2019
Age, Education Level Can Affect One’s Ability to Cope with AS, Study Finds

Progressing disease, older age, and lower education can significantly affect ankylosing spondylitis patients’ ability to cope with the challenges and burden associated with ... Read more
May 17, 2019May 15, 2019
Rare Diseases Constitute a ‘Public Health Issue,’ NCATS Director Warns

With 250 rare diseases newly identified every year, scientists can barely keep up — even as the healthcare system fails millions of Americans whose ... Read more
May 16, 2019May 16, 2019
Ankylosing Spondylitis Patients Face Greater Risk of Depression, Study Finds

Having ankylosing spondylitis more than doubles the risk of developing depression, and the presence of additional chronic conditions exacerbates this risk, a South ... Read more
May 2, 2019May 2, 2019
Lower Dose of TNF Blockers Nearly As Effective and Safer for SpA Patients in Remission, Trial Suggests

Reducing the dose of TNF blockers by about half is nearly as effective as the standard dose taken by ankylosing spondylitis patients who are in stable ... Read more
May 1, 2019April 29, 2019
Three Morning Rituals for Ankylosing Spondylitis Support

I am a big fan of ritualized living. I even wrote a book about it, “Light Magic for Dark Times,” which includes a chapter ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

News

Older Female Ankylosing Spondylitis Patients With Dyslipidemia, More Prone to Osteoporosis
April 24, 2019April 24, 2019
Overall, patients with ankylosing spondylitis (AS) are more likely to develop osteoporosis compared to ...
A Wellness Journey - a Column by Lisa Marie Basile, Columns

On Learning to Find a Balance While Being Chronically Ill
April 24, 2019April 23, 2019
I left a really challenging job situation last year. The job was making me ...
News

Simponi or Remicade Treatment Lowers Healthcare Use, Increases Work Productivity in AS Patients, Study Says
April 22, 2019April 22, 2019
A six-month course of treatment with Janssen‘s Simponi (golimumab) or Remicade (infliximab) significantly reduced the ...
News

AS Patients More Likely to Develop Venous Thromboembolism, Study Says
April 18, 2019April 18, 2019
Patients with ankylosing spondylitis are more likely to develop venous thromboembolism — a condition in which ...
A Wellness Journey - a Column by Lisa Marie Basile, Columns

Finding Balance on Social Media While Managing Chronic Illness
April 17, 2019April 16, 2019
There are many great things about social media. It connects people who would never ...
News

Stopping Infliximab Can Cause Relapses in Ankylosing Spondylitis Patients, Study Says
April 15, 2019April 15, 2019
Stopping treatment with infliximab (brand names, Remsima, Remicade) can lead to relapses in people with ankylosing spondylitis ...

Kidney Issues Should be Considered While Using TNF-Alpha Inhibitors
April 11, 2019April 11, 2019
Despite being rare, kidney complications should be considered in patients with ankylosing spondylitis treated with ...
Higher Serum BMP-2 Levels may be Linked to the Development of Ankylosing Spondylitis, Meta-Analysis Shows
April 8, 2019April 8, 2019
While serum levels of sclerostin — a protein that regulates bone formation — are identical in ...
Simponi Aria Shows Signs of Efficacy in Patients with Active Ankylosing Spondylitis
April 4, 2019April 4, 2019
How Stress Impacted My Ankylosing Spondylitis
March 27, 2019March 25, 2019
High Chitotriosidase Levels Linked to Ankylosing Spondylitis Activity
March 25, 2019March 25, 2019
Study Examines Differences in Gut Contents of Male, Female Ankylosing Spondylitis Patients
March 20, 2019March 20, 2019

Diet, Air Pollution May Play Role in Ankylosing Spondylitis Activity, Study Suggests
March 18, 2019March 18, 2019
A high-fat diet and long-term exposure to air pollution are both associated with worse ...
Brexit Could Have Real Effects for UK Rare Disease Patients, Experts Warn
March 14, 2019
Anti-TNF Alpha Therapy Improves Exercise Capacity After Four Months of Treatment, Study Suggests
March 13, 2019March 13, 2019
My Shingles Story: How It Happened and What I Did in Response
March 13, 2019March 12, 2019

High Levels of C-reactive Protein Can Predict Risk for Future Ankylosing Spondylitis, Study Finds
March 6, 2019March 6, 2019
High levels of C-reactive protein, a marker of systemic inflammation, at the onset of ...
NIH Rare Disease Day Highlights Joint Networks Advancing Array of Research
March 6, 2019March 5, 2019
Anti-TNF-Alpha Therapies Linked to Reduced Lumbar Spine Deformities, Study Shows
March 4, 2019March 4, 2019

News

Ankylosing Spondylitis Patients Have Higher Risk of Blood Clots, Study Suggests
February 27, 2019March 27, 2019
Ankylosing spondylitis (AS) patients have a more than 50% increased risk of developing blood ...
A Wellness Journey - a Column by Lisa Marie Basile, Columns

3 Ways to Get Out of an Ankylosing Spondylitis Slump
February 27, 2019February 26, 2019
Life can be affirming and beautiful, but it also can be hard, random, and ...
News

WODC 2019 Organizers Expect 1,200 to Attend Rare Disease Conference in April
February 25, 2019February 25, 2019
The world’s biggest gathering of rare disease researchers, patient groups, pharmaceutical executives, and government ...
News

Vienna to Host RARE2019 Meeting on Rare Diseases
February 25, 2019February 20, 2019
About 100 scientists, researchers, pharmaceutical executives, and others will converge on Austria’s capital city ...
A Wellness Journey - a Column by Lisa Marie Basile, Columns

What Ankylosing Spondylitis Taught Me About Myself
February 20, 2019February 19, 2019
Getting diagnosed with ankylosing spondylitis (AS) wasn’t just about figuring out (finally!) which disease ...
News

Plant Compound Emodin Could be Used as Treatment for AS, Study Says
February 18, 2019February 18, 2019
Emodin, a plant compound used in traditional Chinese medicine, has potent anti-inflammatory and anti-rheumatic ...

March 7, 2018March 7, 2018

Cosentyx Leads to Long-Term Improvement in AS Patients, Phase 3 Trial Shows

News

Results from a Phase 3 clinical trial show that treatment with Cosentyx (secukinumab) led to fast, significant, and sustained symptom improvement in patients with active ankylosing spondylitis (AS). Improvements were particularly noticeable in patients who had never ... Read more

Subscribe to our mailing list

Pin It on Pinterest